Leonard Capital Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Leonard Capital Management’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,273	Closed	-$325K	–	85
2015 Q2	$325K	Hold	2,273	–	–	0.11%	109
2015 Q1	$307K	Buy	2,273 +773	+52%	+$126K	0.11%	119
2014 Q4	$269K	Buy	+1,500	New	+$267K	0.07%	168
2014 Q1	–	Sell	-1,491	Closed	-$717K	–	150
2013 Q4	$717K	Hold	1,491	–	–	0.28%	110
2013 Q3	$719K	Hold	1,491	–	–	0.29%	112
2013 Q2	$701K	Buy	+1,491	New	+$676K	0.27%	120

Other funds holding IDXG

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $126M AUM 15.32% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Leonard Capital Management's IDXG Position: Q3 2015 in Review

Leonard Capital Management sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q3 2015, closing a stake of 2,273 shares — an estimated $325K sold.

Leonard Capital Management first reported a position in IDXG in Q2 2013 and held it in 6 quarters. The position peaked at $719K in Q3 2013. 22 funds tracked by Wall St. Rank hold IDXG as of Q3 2015.

Leonard Capital Management reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
Leonard Capital Management sold 2,273 Interpace Biosciences, Inc. Common Stock shares in Q3 2015, an estimated $325K.
Leonard Capital Management first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 6 quarters.
Leonard Capital Management's Interpace Biosciences, Inc. Common Stock position peaked at $719K in Q3 2013.
22 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q3 2015.

Based on Leonard Capital Management's 13F filing for Q3 2015.